Izumi T, Tajima S, Nishikawa T
Department of Dermatology, Keio University, School of Medicine, Tokyo, Japan.
Arch Dermatol Res. 1995;287(5):417-20. doi: 10.1007/BF00373421.
Decorin mRNA levels, the content of decorin and the synthesis of dermatan sulphate in skin fibroblasts from patients with systemic and localized scleroderma were investigated. Approximately a 2.2-fold increase in decorin mRNA levels, was found by Northern blot analysis in localized scleroderma, but no significant changes were found in systemic scleroderma. Decorin, as measured by an immunoblot assay, was increased 2.6-fold in fibroblast cultures from localized scleroderma but not in those from systemic scleroderma. In contrast, the synthesis of dermatan sulphate was similar in both conditions. These results indicate that altered decorin gene expression causes abnormal proteoglycan metabolism in localized scleroderma.
研究了系统性和局限性硬皮病患者皮肤成纤维细胞中核心蛋白聚糖(decorin)mRNA水平、核心蛋白聚糖含量及硫酸皮肤素的合成情况。通过Northern印迹分析发现,局限性硬皮病中核心蛋白聚糖mRNA水平约增加了2.2倍,但系统性硬皮病中未发现显著变化。通过免疫印迹分析测定,局限性硬皮病成纤维细胞培养物中的核心蛋白聚糖增加了2.6倍,而系统性硬皮病的成纤维细胞培养物中则未增加。相比之下,两种情况下硫酸皮肤素的合成相似。这些结果表明,核心蛋白聚糖基因表达改变导致局限性硬皮病中蛋白聚糖代谢异常。